S. Cornet

发表

Induction of multiple CD 8 + T cell responses against the inducible Hsp 70 employing an Hsp 70 oligoepitope peptide

F. Lemonnier, I. Miconnet, J. Abastado, 2022 .

CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope.

F. Lemonnier, I. Miconnet, K. Kosmatopoulos, 2006, Vaccine.

EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes.

F. Lemonnier, I. Miconnet, S. Chouaib, 2003, Cancer research.

Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies

E. Matera, C. Dumontet, O. Trédan, 2016, Molecular Cancer Therapeutics.

STEAP, a prostate tumor antigen, is a target of human CD8+ T cells

J. Soria, F. Lemonnier, I. Miconnet, 2006, Cancer Immunology, Immunotherapy.

A Phase I Study of the Optimized Cryptic Peptide TERT572Y in Patients with Advanced Malignancies

I. Miconnet, P. Kanellou, M. Spyropoulou, 2006, Oncology.

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

P. Opolon, J. Davoust, F. Lemonnier, 2004, The Journal of clinical investigation.

Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA‐A*0201‐restricted epitopes

F. Lemonnier, I. Miconnet, J. Abastado, 2004, International journal of cancer.

Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity.

F. Lemonnier, I. Miconnet, J. Menez, 2006, Vaccine.

Gastrite, métaplasie intestinale et cancer.

F. Carnot, A. Kassem, S. Cornet, 1973 .

Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies: A Phase I clinical study

I. Miconnet, M. Spiropoulou, P. Kanellou, 2005 .